In the following sections, we describe the mechanisms by which SIRT1 and the modulation of NAD+ metabolism are involved in the pathophysiology of kidney diseases [12,74,75], with special emphasis on SIRT1 alterations in AKI, chronic renal failure, obesity, and DKD. This evidence concerns the gene SIRT1 and diabetic kidney disease.